Market Cap 8.62M
Revenue (ttm) 3.00M
Net Income (ttm) 39.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 1,326.33%
Debt to Equity Ratio 0.00
Volume 155,200
Avg Vol 548,240
Day's Range N/A - N/A
Shares Out 29.67M
Stochastic %K 20%
Beta 1.09
Analysts Sell
Price Target $9.50

Company Profile

PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precance...

Industry: Medical Devices
Sector: Healthcare
Phone: 917 813 1828
Address:
360 Madison Avenue, 25th Floor, New York, United States
quegoalasoche
quegoalasoche Dec. 20 at 11:14 AM
0 · Reply
BUKUDATBULL
BUKUDATBULL Dec. 19 at 6:24 PM
$PFSA & $PAVM These are the ones I got my eyes 👀 & $$$ on 🏧 Take a look for itself if u want/ain't got a any prospects currently; but REMEMBER THIS IS NOT FINANCIAL ADVICE IN ANY WAY/BUYER BEWARE
0 · Reply
TheTonyDean
TheTonyDean Dec. 18 at 10:20 PM
$PAVM “Imminent”. My ass. We got played by the management who is failing with the only thing that was important: coverage.
1 · Reply
dmc4321
dmc4321 Dec. 18 at 7:43 PM
$LUCD & $PAVM Its another @oaksapollo post so its another deliberate LIE! PAVM owns 31 million shares of LUCD and struck an agreement with PAVM insiders that they could vote their 7M shares, but PAVM does NOT own the 7M "insiders shares". So Oaksapollo is double counting after being corrected MULTIPLE times.
0 · Reply
BigJuicy
BigJuicy Dec. 18 at 5:44 PM
$PAVM .25!!!!!! Let’s goooo need to flush everyone out before this runs 500% in a day
0 · Reply
dmc4321
dmc4321 Dec. 17 at 3:30 AM
$PAVM & $LUCD Its an @oaksapollo post so it is a LIE!! You should read @Lets_Go_Brndn post on the Grok analysis of the MolDX process. Its the detail that matters where it says that 9+ months is the normal time for a decision after a CAC meeting and the only one that was SHORTER was the EsoGuard initial submission which was denied. It is only now that I realize that logically if something is "NOT COVERED" then ALL the information that you would require to declare it "COVERED" was never gathered, let alone discussed and considered. Plus you need to explain to everyone why you are now changing it to covered and try and get agreement that everybody is happy with that decision. Thats is why "Reconsiderations" take LONGER than original submissions. More information is required and more work is involved. Lishan and Dennis should have known this. So either they do and they LIE, or they DONT and they are IDIOTS. there is no 3rd answer. Plus there is a HARD DEFAULT looming in MAY 2026
0 · Reply
BigJuicy
BigJuicy Dec. 16 at 12:21 AM
$PAVM .25 coming
0 · Reply
BigJuicy
BigJuicy Dec. 12 at 12:38 PM
$PAVM https://www.gurufocus.com/news/3240534/ascendiant-capital-lowers-price-target-for-pavmed-pavm-to-1700-pavm-stock-news?utm_source=chatgpt.com
1 · Reply
MrSlick27
MrSlick27 Dec. 10 at 9:14 PM
$PAVM 0.0239 price before RS wtaf
0 · Reply
tds_
tds_ Dec. 10 at 4:34 PM
$PAVM Around 60k shares traded so far...@ appx $0.36/shr...A whopping $20K ...good times.
0 · Reply
Latest News on PAVM
PAVmed Inc. (PAVM) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 11:31 AM EST - 5 weeks ago

PAVmed Inc. (PAVM) Q3 2025 Earnings Call Transcript


PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript

May 15, 2025, 1:58 PM EDT - 7 months ago

PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript


PAVmed Inc. (PAVM) Q4 2024 Earnings Call Transcript

Mar 25, 2025, 11:08 AM EDT - 9 months ago

PAVmed Inc. (PAVM) Q4 2024 Earnings Call Transcript


quegoalasoche
quegoalasoche Dec. 20 at 11:14 AM
0 · Reply
BUKUDATBULL
BUKUDATBULL Dec. 19 at 6:24 PM
$PFSA & $PAVM These are the ones I got my eyes 👀 & $$$ on 🏧 Take a look for itself if u want/ain't got a any prospects currently; but REMEMBER THIS IS NOT FINANCIAL ADVICE IN ANY WAY/BUYER BEWARE
0 · Reply
TheTonyDean
TheTonyDean Dec. 18 at 10:20 PM
$PAVM “Imminent”. My ass. We got played by the management who is failing with the only thing that was important: coverage.
1 · Reply
dmc4321
dmc4321 Dec. 18 at 7:43 PM
$LUCD & $PAVM Its another @oaksapollo post so its another deliberate LIE! PAVM owns 31 million shares of LUCD and struck an agreement with PAVM insiders that they could vote their 7M shares, but PAVM does NOT own the 7M "insiders shares". So Oaksapollo is double counting after being corrected MULTIPLE times.
0 · Reply
BigJuicy
BigJuicy Dec. 18 at 5:44 PM
$PAVM .25!!!!!! Let’s goooo need to flush everyone out before this runs 500% in a day
0 · Reply
dmc4321
dmc4321 Dec. 17 at 3:30 AM
$PAVM & $LUCD Its an @oaksapollo post so it is a LIE!! You should read @Lets_Go_Brndn post on the Grok analysis of the MolDX process. Its the detail that matters where it says that 9+ months is the normal time for a decision after a CAC meeting and the only one that was SHORTER was the EsoGuard initial submission which was denied. It is only now that I realize that logically if something is "NOT COVERED" then ALL the information that you would require to declare it "COVERED" was never gathered, let alone discussed and considered. Plus you need to explain to everyone why you are now changing it to covered and try and get agreement that everybody is happy with that decision. Thats is why "Reconsiderations" take LONGER than original submissions. More information is required and more work is involved. Lishan and Dennis should have known this. So either they do and they LIE, or they DONT and they are IDIOTS. there is no 3rd answer. Plus there is a HARD DEFAULT looming in MAY 2026
0 · Reply
BigJuicy
BigJuicy Dec. 16 at 12:21 AM
$PAVM .25 coming
0 · Reply
BigJuicy
BigJuicy Dec. 12 at 12:38 PM
$PAVM https://www.gurufocus.com/news/3240534/ascendiant-capital-lowers-price-target-for-pavmed-pavm-to-1700-pavm-stock-news?utm_source=chatgpt.com
1 · Reply
MrSlick27
MrSlick27 Dec. 10 at 9:14 PM
$PAVM 0.0239 price before RS wtaf
0 · Reply
tds_
tds_ Dec. 10 at 4:34 PM
$PAVM Around 60k shares traded so far...@ appx $0.36/shr...A whopping $20K ...good times.
0 · Reply
anachartanalyst
anachartanalyst Dec. 10 at 11:14 AM
$PAVM https://anachart.com/wp-content/uploads/ana_temp/1765365276_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Dec. 10 at 10:27 AM
Ascendiant Capital has adjusted their stance on PAVmed ( $PAVM ), setting the rating to Buy with a target price of 20 → 17.
0 · Reply
Carter113
Carter113 Dec. 9 at 5:09 PM
$LUCD $PAVM Chat gpt: Conclusion A nearly 12,000-patient real-world diagnostic performance study is extremely rare. Only a handful of diagnostic platforms in the last 20 years have published datasets of this magnitude — and Lucid’s is arguably the most impactful real-world evidence ever reported for a first-of-its-kind cancer screening test. This will be heavily weighted by: MolDX Commercial payers Guideline committees Strategic acquirers And it places EsoGuard in the same conversation as the most commercially successful diagnostics in history.
2 · Reply
oaksapollo
oaksapollo Dec. 8 at 9:46 PM
$PAVM anyone know what is going on here? Trading 1 share every few seconds, been gong on since close. Very weird right?
1 · Reply
LPlates
LPlates Dec. 6 at 1:00 AM
$PAVM @tommyrulz so were you as confident when youposted this about PAVM as you are about $LUCD being $5 at the end of the week? BTW the % loss DOES NOT include the 15 for 1 reverse split NOR the either 10 to 1 MINIMUM Reverse split up to 30 to 1 voted on Today. So besides being down nearly 90% you have to DIVIDE that by ANOTHER 150. 😬. 😬 😬
0 · Reply
traderjoe2018
traderjoe2018 Dec. 5 at 11:05 PM
$PAVM sad state of affairs here. Which I never bought into pavm. It has donenothing but go down for years.
0 · Reply
quegoalasoche
quegoalasoche Dec. 5 at 10:02 PM
0 · Reply
quegoalasoche
quegoalasoche Dec. 5 at 7:35 PM
$PAVM $LUCD They did it with Lucky Strike in the 1930s. They’re doing it again — but now with vapes, synthetic nicotine, and vitamin-E carriers that stick to your esophagus and lungs like glue. Every decade they reinvent the same scam: 1️⃣ Create the addiction. Push chemical-coated nicotine clouds in flavors that taste like childhood. Slip in carriers like Vitamin-E acetate — a substance that becomes waxy when heated → sticks to your lungs, throat, and airways. Perfect design: cheap to produce addictive “safer alternative” marketing and… quiet long-term damage nobody connects until 10 years later Same playbook cigarettes used. Just with better flavoring and better data science. --- 2️⃣ Wait for the health fallout. Suddenly — “mysterious spikes” in: chronic cough swallowing problems esophageal irritation Barrett’s esophagus and early-stage throat cancers And guess who steps in?
2 · Reply
tds_
tds_ Dec. 5 at 3:08 PM
$PAVM No surprise, the majority of shareholders voted in favor of the Reverse Split proposal at today's 10am special mtg. Range from 10-to-1 to 30-to-1 TBD by board. I believe the stock has until Jan 19, 2026 to meet Nasdaq requirements. GLTA.
0 · Reply
Carter113
Carter113 Dec. 5 at 12:19 AM
$LUCD $PAVM Desperate is posting the same BS under multiple handles, several times a day Dave!!! You don’t understand nearly as much as you think you do!!! The only on freaking out here is 🫵 knowing that this is about to go much higher!!!
3 · Reply
Carter113
Carter113 Dec. 4 at 10:57 PM
$LUCD $PAVM https://intheloop.oxfordbiodynamics.com/blog/the-rise-of-patient-friendly-diagnostics-redefining-cancer-screening-in-the-clinic-and-at-home
1 · Reply
BigJuicy
BigJuicy Dec. 4 at 2:13 PM
$PAVM straight down for 5 years
0 · Reply